Feb 18, 2021
Therapeutic Solutions International Spin-Off Campbell Neurosciences Announces Positive Clinical Trial Results for Campbell Score Blood Based Suicide Prediction
Oct 19, 2020
Therapeutic Solutions International Reports Positive Preclinical Data on Multiple Sclerosis using NanoStilbene(TM)
Aug 21, 2020
Therapeutic Solutions International Files Patent on Campbell Score(TM): The First Quantitative Tool for Assessment of Suicidal Propensity based on Immunological Markers
Aug 11, 2020
Therapeutic Solutions International Launches Campbell Neurosciences Division aimed at Biologically Identifying and Repairing Suicide-Prone Brains
Jul 22, 2020
Therapeutic Solutions International Reports Unexpected Findings of Synergy between QuadraMune(TM) and Diabetes Drug Metformin in Animal Models of COVID-19 Lung Damage
Jun 11, 2020
Therapeutic Solutions International Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer
Jun 01, 2020
San Diego Top Doctor Collaborates with Therapeutic Solutions International to Report QuadraMune(TM) Immune Boosting Data in Clinical Trial
May 05, 2020
Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune(TM)
Jan 21, 2020
Therapeutic Solutions International Enters into Multi-Million Dollar Master Sales Agreement with Publicly Traded iBrands Corporation
Jan 08, 2020
Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene
Dec 23, 2019
Therapeutic Solutions International Enters Into Multi-million Dollar Master Sales Agreement With WCTE, Inc.
Dec 16, 2019
Therapeutic Solutions International Signs Letter of Intent to License Adult Stem Cell Therapy for Treatment of Chronic Traumatic Encephalopathy to WCTE, Inc., a Wes Chandler Company
Dec 12, 2019
Therapeutic Solutions International Enters Into Multi-million Dollar Master Sales Agreement With Tiva Bio
Nov 11, 2019
Therapeutics Solutions International Signs Agreement With Beijing Regenesis Biotechnology to License and Develop Patent for Anti-aging Use of Cord Blood Plasma and NanoStilbene
Nov 04, 2019
Therapeutic Solutions International Reports Augmentation of Rejuvenating Activity of Cord Blood Plasma by Pterostilbene
Feb 27, 2018
Therapeutic Solutions International, Inc. Recruits Top Doctor of San Diego to Scientific Advisory Board